This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy International Europe

Savings Deadline Expires In:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
2-4 December 2024
Convention Centre DublinDublin, Ireland

Yu-Tsan (Richard) Liu
Sr. Scientist at UCB Pharma
Speaker

Profile

Yu-Tsan (Richard) Liu is a project lead and Sr. scientist in UCB Pharma’s Gene therapy Process Sciences Downstream team. Prior to joining UCB Pharma, he has worked in in WuXi Biologics in China and several biopharma companies in Taiwan leading several NMPA/FDA IND-enabling biologics downstream process development / Tox scale-up projects and late-stage BLA-enabling biologics downstream projects with GSK, MSD, Merck and several Chinese companies. He has more than 10 years of experience in the downstream, QC/QA and analytics. Prior to joining industry, Richard obtained a Master in Anatomy and Cellular Biology from the University of Iowa (U.S.), a Master in Chemistry from National Central University (Taiwan) and a BS in Biochemical Science and Technology from National Taiwan University (Taiwan).

Agenda Sessions

  • Challenges In rAAV Downstream Process And Viral Safety

    16:00